Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$42.05 - $47.77 $1,261 - $1,433
-30 Reduced 0.22%
13,456 $586,000
Q1 2022

May 13, 2022

SELL
$40.23 - $47.74 $38,017 - $45,114
-945 Reduced 6.55%
13,486 $587,000
Q4 2021

Feb 01, 2022

BUY
$38.88 - $45.31 $23,872 - $27,820
614 Added 4.44%
14,431 $636,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $16,446 - $18,299
-424 Reduced 2.98%
13,817 $528,000
Q2 2021

Aug 10, 2021

BUY
$36.52 - $41.46 $163,573 - $185,699
4,479 Added 45.88%
14,241 $567,000
Q1 2021

Apr 30, 2021

BUY
$34.27 - $40.01 $334,543 - $390,577
9,762 New
9,762 $348,000
Q4 2020

Jan 25, 2021

SELL
$34.07 - $39.94 $160,367 - $187,997
-4,707 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$38.11 - $42.99 $576,794 - $650,653
-15,135 Reduced 76.28%
4,707 $177,000
Q2 2020

Aug 13, 2020

BUY
$37.87 - $43.58 $16,473 - $18,957
435 Added 2.24%
19,842 $809,000
Q1 2020

Apr 21, 2020

BUY
$32.47 - $48.83 $31,528 - $47,413
971 Added 5.27%
19,407 $735,000
Q4 2019

Feb 12, 2020

SELL
$42.0 - $48.25 $125,412 - $144,074
-2,986 Reduced 13.94%
18,436 $866,000
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $35,766 - $38,471
884 Added 4.3%
21,422 $914,000
Q2 2019

Aug 15, 2019

BUY
$39.4 - $42.7 $775,234 - $840,165
19,676 Added 2282.6%
20,538 $822,000
Q1 2019

Jul 01, 2019

SELL
$38.57 - $42.69 $762,528 - $843,981
-19,770 Reduced 95.82%
862 $20.6 Million
Q1 2019

May 13, 2019

BUY
$38.57 - $42.69 $783,703 - $867,418
20,319 Added 6491.69%
20,632 $862,000
Q4 2018

Feb 12, 2019

BUY
$37.8 - $42.69 $11,566 - $13,063
306 Added 4371.43%
313 $8,000
Q3 2018

Nov 05, 2018

SELL
$39.75 - $42.69 $560,037 - $601,459
-14,089 Reduced 99.95%
7 $285,000
Q2 2018

Aug 15, 2018

BUY
$39.61 - $42.76 $398,912 - $430,635
10,071 Added 250.21%
14,096 $568,000
Q1 2018

May 07, 2018

BUY
$36.18 - $40.15 $145,624 - $161,603
4,025 New
4,025 $157,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.